1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal ...

908 Margrethe Nielsen et al.
40. Schatzberg A. F., Haddad P., Kaplan E. M. Serotonin
re-uptake inhibitor discontinuation syndrome: a hypothetical
definition. Discontinuation panel. J Clin Psychiatry
1997; 58: 5–10.
41. Supplement J Clin Psychiatry 1997; 58.
42. Medicines and Healthcare products Regulatory Agency
(MHRA) [internet]. Summary of the meeting of the Committee
on Safety of Medicines Held on Thursday 26 March 1998
[Cited March 7]. London UK: MHRA; 2010. Available at:
http://www.mhra.gov.uk/home/groups/l-cs-el/
documents/committeedocument/con003341.pdf (accessed
9 June 2011) (Archived by WebCite ® at http://www.
webcitation.org/5zJxOqs7M).
43. Medicines and Healthcare products Regulatory Agency
(MHRA) [internet]. Minutes of the meeting of the CSM Expert
Group on the Safety of SSRIs held on Tuesday 22. July 2003.
London UK: MHRA; 2010. Available at: http://www.
mhra.gov.uk/home/groups/pl-p/documents/committee
document/con003484.pdf (accessed 9 June 2011)
(Archived by WebCite ® at http://www.webcitation.org/
5zJxWqf2V).
44. European Medicines Agency (EMA) [internet]. London:
EMA; 1995–2010. EMEA/CPMP/2775/99; updated 2009
Dec 18 [cited 2009 April 18]. 1999. Available at: http://
www.ema.europa.eu/docs/en_GB/document_library/
Scientific_guideline/2009/09/WC500003357.pdf
(accessed 9 June 2011) (Archived by WebCite ® at http://
www.webcitation.org/5zJxeoego).
45. Medicines and Healthcare products Regulatory Agency
(MHRA) [internet]. Report of the CSM expert working group
on the safety of selective serotonin reuptake inhibitor antidepressants
2004 [Cited 2009 June 7]. London UK: MHRA; 2010.
Available at: http://www.mhra.gov.uk/home/groups/pl-p/
documents/drugsafetymessage/con019472.pdf (accessed
9 June 2011) (Archived by WebCite ® at http://www.
webcitation.org/6467vFAnk).
46. Abraham J., Davis C. Drug evaluation and the permissive
principle: continuities and contradictions between standards
and practices in antidepressant regulation. Soc Stud
Sci 2009; 39: 569–98.
47. National Institute for Clinical Excellence. CG90. Depression:
The Treatment and Management of Depression in Adults.
London: National Institute for Clinical Excellence; 2007.
48. Selective serotonin re-uptake inhibitors and withdrawal
reactions. WHO Drug Inf 1998; 12: 136–8.
49. Coupland N. J., Bell C. J., Potokar J. P. Serotonin reuptake
inhibitor withdrawal. J Clin Pharmacol 1996; 16: 356–
62.
50. WHO Technical Report series no 915. WHO Expert Committee
on Drug Dependence. Thirty-third Report. Geneva:
WHO; 2003.
51. Seroxat secrets [internet]. [Cited 16 December 2009]. Available
at: http://www.seroxatsecrets.wordpress.com/about/
(accessed 9 June 2011) (Archived by WebCite ® at http://
www.webcitation.org/5zJxuCs2Y).
52. Seroxat and SSRI User Group [internet]. Seroxat user group
doctor pack. [Cited 19 December 2008]. Available at: http://
www.seroxatusergroup.org.uk/Seroxat%20User%20
Group%20Doctor%20Pack.pdf (accessed 9 June 2011)
(Archived by WebCite ® at http://www.webcitation.org/
5zJxzFG7M).
53. Leydon G. M., Rodgers L., Kendrick T. A qualitative
study of patient views on discontinuing long-term selective
serotonin reuptake inhibitors. Fam Pract 2007; 24:
570–5.
54. Rosenbaum J. F., Fava M., Hoog S. L., Ascroft R. C., Krebs W.
Selective serotonin reuptake inhibitor discontinuation
syndrome: a randomized clinical trial. Biol Psychiatry 1998;
44: 77–87.
55. Lader M. Benzodiazepine dependence. Prog Neuropsychopharmacol
Biol Psychiatry 1984; 8: 85–95.
Supporting information
Additional Supporting Information may be found in the
online version of this article:
Appendix S1 Dependence criteria.
Appendix S2 References.
Please note: Wiley-Blackwell are not responsible for
the content or functionality of any supporting materials
supplied by the authors. Any queries (other than missing
material) should be directed to the corresponding author
for the article.
© 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 900–908